Tumour necrosis factor-α inhibitors are glucocorticoid-sparing in rheumatoid arthritis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Resumé

Rheumatoid arthritis (RA) is a chronic disease with autoimmune traits of unknown aetiology which primarily affects synovial joints. Glucocorticoids (GCs) are still widely used in RA treatment despite the expanding use of targeted and very efficient agents. The objective of this study was to assess the impact of treatment with tumour necrosis factor-α inhibitors (TNFi) on GC utilization in real-life practice among Danish RA patients.
OriginalsprogEngelsk
TidsskriftDanish Medical Bulletin (Online)
Vol/bind58
Udgave nummer4
Sider (fra-til)A4257
ISSN1603-9629
StatusUdgivet - 2011

Fingeraftryk

Glucocorticoids
Tumor Necrosis Factor-alpha
Joints

Citer dette

@article{3452be37f6474c428df3fb54bc2937d0,
title = "Tumour necrosis factor-α inhibitors are glucocorticoid-sparing in rheumatoid arthritis",
abstract = "Rheumatoid arthritis (RA) is a chronic disease with autoimmune traits of unknown aetiology which primarily affects synovial joints. Glucocorticoids (GCs) are still widely used in RA treatment despite the expanding use of targeted and very efficient agents. The objective of this study was to assess the impact of treatment with tumour necrosis factor-α inhibitors (TNFi) on GC utilization in real-life practice among Danish RA patients.",
author = "Nilsson, {Anna Christine} and Christensen, {Anne Friesgaard} and Peter Junker and Lindegaard, {Hanne Merete}",
year = "2011",
language = "English",
volume = "58",
pages = "A4257",
journal = "Danish Medical Journal",
issn = "1603-9629",
publisher = "DANISH MEDICAL ASSOC",
number = "4",

}

Tumour necrosis factor-α inhibitors are glucocorticoid-sparing in rheumatoid arthritis. / Nilsson, Anna Christine; Christensen, Anne Friesgaard; Junker, Peter; Lindegaard, Hanne Merete.

I: Danish Medical Bulletin (Online), Bind 58, Nr. 4, 2011, s. A4257.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - Tumour necrosis factor-α inhibitors are glucocorticoid-sparing in rheumatoid arthritis

AU - Nilsson, Anna Christine

AU - Christensen, Anne Friesgaard

AU - Junker, Peter

AU - Lindegaard, Hanne Merete

PY - 2011

Y1 - 2011

N2 - Rheumatoid arthritis (RA) is a chronic disease with autoimmune traits of unknown aetiology which primarily affects synovial joints. Glucocorticoids (GCs) are still widely used in RA treatment despite the expanding use of targeted and very efficient agents. The objective of this study was to assess the impact of treatment with tumour necrosis factor-α inhibitors (TNFi) on GC utilization in real-life practice among Danish RA patients.

AB - Rheumatoid arthritis (RA) is a chronic disease with autoimmune traits of unknown aetiology which primarily affects synovial joints. Glucocorticoids (GCs) are still widely used in RA treatment despite the expanding use of targeted and very efficient agents. The objective of this study was to assess the impact of treatment with tumour necrosis factor-α inhibitors (TNFi) on GC utilization in real-life practice among Danish RA patients.

M3 - Journal article

C2 - 21466765

VL - 58

SP - A4257

JO - Danish Medical Journal

JF - Danish Medical Journal

SN - 1603-9629

IS - 4

ER -